AbbVie is nearing a deal to acquire inflammatory disease drug developer Apogee Therapeutics for about $10.9 billion in cash, the Financial Times reported on Friday, citing people familiar with the matter. The deal...
Pharmaceutical
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon
Indian generic drug giant Aurobindo Pharma announced on Friday that it is on the verge of pulling off a major expansion in the United States after clearing a critical regulatory hurdle. The Hyderabad-based...
Zydus Lifesciences completes acquisition of Assertio
Zydus Lifesciences Ltd on Tuesday said it has completed the USD 166.4 million acquisition of US-based pharma company Assertio Holdings Inc. The company has successfully completed the cash tender offer, through wholly...
$10. 6 billion deal: GSK to buy US cancer specialist Nuvalent
British pharmaceutical group GSK announced Tuesday a $10.6-billion deal for Nuvalent, a Boston-based specialist in cancer treatments, furthering its push into both oncology and the United States. The deal includes...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. The companies were locked in...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. Here are some details: The companies...
Shilpa Biocare to acquire 30.4% stake in Barcelona-based Gate2Brain
Shilpa Medicare announced that its wholly owned subsidiary, Shilpa Biocare intends to make a strategic equity partnership of 30.4% in Gate2Brain. The investment of Euro 7 million includes cash infusion of Euro 0.5...
Marksans Pharma to acquire Netherlands-based QliniQ B.V.
Marksans Pharma announced that it has entered into a definitive agreement to acquire 100% of the share capital of QliniQ B.V., a profitable Netherlands-based pharmaceutical company with established front-end sales...
True North buys 25% stake in pharma co Embio
Homegrown private equity firm True North will acquire a minority stake in Embio Ltd, a regulated markets-focused manufacturer of Active Pharmaceutical Ingredients (APIs), True North announced on Wednesday. According to...
Government okays Skymap Pharmaceuticals’ Rs 121-cr bid to buy IMPCL
The government has approved strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) to Skymap Pharmaceuticals Pvt Ltd for over Rs 121 crore, the finance ministry said on Tuesday. The government had...
Lantheus weighs potential $7 billion sale after Curium’s offer, Bloomberg News reports
Radiopharmaceutical-focused company Lantheus Holdings is weighing a potential sale after getting a takeover offer from private-equity backed Curium Pharma that values it at about $7 billion, Bloomberg News reported on...
HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030
HAB Pharma and Signature Phytochemicals have completed a merger through a slump sale, bringing both companies under a single consolidated entity. Finalized in March 2026, the merger was undertaken to streamline...
